TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: stent lumen image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-oriented reward learning performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HAQ‐DI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Decrease in log-FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decrease in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of severe/very severe exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: nasal region fluorescein staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dryness scores of 0
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cocaine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NEFA responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: patient-reported moderate/severe pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum level of TNF‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VFQ-25 composite scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: OSDI composite scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Diastolic Blood Pressure (MDP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived importance of school-based PA opportunities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction in air-pollution associated deteriorated respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dynamic balance (Star Excursion Balance Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interviewer-rated motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anticipatory pleasure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: recovery-oriented goals attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Severity and prognosis of ascites grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived swallowing function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of intractable esophageal stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average endoscopic treatment times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence time of esophageal stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average procedure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean frequency intake of red/orange vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endoscopist rating of procedure tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of propofol used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of adverse events (coughing and retching)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of clinically important PONV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Margin Rate (PMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall mortality for AAA cases
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of drug-related CNS TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of drug-related CNS TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Osseous integration of the cage surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI, VAS and EQ-5D improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proptosis measurement consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total composite scores of healthy-lifestyle behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 60-min of moderate physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in type-I interferons (IFNa and IFNb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS‐CoV2‐specific IgM and IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of fever, cough, headache and myalgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of SICs conducted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net incremental QALY gain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PTV (Prosthetic Tooth Mobility)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant adherence to Yoga sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced Vital Capacity percent predicted (FVC%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rate of recurrent binary restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rehospitalization rates at 90-days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Quality of surgical scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of responders (>50% reduction in MADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in objectively measured adherence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful sedation with midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c adjusted mean difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WHO-5 index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PAID score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: median intracranial progression-free survival (iPFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of syncopal or presyncopal events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor Growth Rate (TGR) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause death prediction accuracy
Endpoint domain: Mortality/survival
Primary endpoint: Composite outcome prediction accuracy
Endpoint domain: Mortality/survival
Primary endpoint: Fried score trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: St George's Respiratory Questionnaire (SGRQ) total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: global QoR-40 K score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Engraftment of donor strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevotella to Bacteroides (P/B) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: State Anxiety Scale (SAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of total oocytes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of MII oocytes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour energy balance (EB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FACT-G7 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Migration and tube formation ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of neoplasms
Endpoint domain: Adverse events/effects
Primary endpoint: Compression quality during CPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident myocardial infarction, stroke, heart failure hospitalization, and death
Endpoint domain: Mortality/survival
Primary endpoint: MDS‐UPDRS part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Preference for SC-t over IV-t
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge towards epilepsy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude towards epilepsy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consent rate in randomized trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: variceal rebleeding rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of hepatic encephalopathy
Endpoint domain: Adverse events/effects
Primary endpoint: tumour regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: combined tumour and node downstaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fat Free Mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief at 2 h after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful insertion at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to successful device insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ease of device insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incident THR/TKR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HBVr occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: zone diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased live bacteria after challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: higher serum vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Final fasting serum glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h central systolic BP (c-SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-h pulse wave velocity (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: functional independence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Plasma exposure to sofosbuvir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of sofosbuvir
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in viral titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants making an informed choice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adequate overall knowledge about cataract surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intention to undergo surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of at least one DME item
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Eustachian tube dysfunction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of complications and recurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 25OHD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative NRS pain values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to get out of bed postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of intraoperative arrhythmia
Endpoint domain: Adverse events/effects
Primary endpoint: post‐prandial discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PK bioequivalence of INTP24 to US‐bevacizumab and EU‐bevacizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and immunogenicity profiles
Endpoint domain: Adverse events/effects
Primary endpoint: Harris Hip Score (HHS) at 12 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sEMG signal of the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA of the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBI of the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate-type reactions (stinging and redness)
Endpoint domain: Adverse events/effects
Primary endpoint: Estimated Stroke Volume (SBV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: GFR values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral oxygen saturation at intraoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month diarrhea prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Stunting in children <2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flap dissection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall OR time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tumor pathological staging AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor pathological grading AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mental/behavioral ED visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prothrombotic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events or interactions
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of Autism Spectrum Disorder (ASD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developmental delay (DD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total effectiveness rate at 12 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of acute kidney injury
Endpoint domain: Adverse events/effects
Primary endpoint: Gained/maintained visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lost ≥ 5 ETDRS letters
Endpoint domain: Adverse events/effects
Primary endpoint: Unplanned 30-day hospitalization and/or ED return visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prediction of Gestational Diabetes Mellitus (GDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of Hypertensive Disorders of Pregnancy (HDP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of Large for Gestational Age (LGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accelerometer measured physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in identification of AKI risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment for AKI (volume expansion and withholding nephrotoxic medications)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of chronic decline of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in DFROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute heart failure hospitalisations prevented
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in ISI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in HADS anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in HADS depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geometric mean concentrations (GMCs) of anti-HBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rebound pain incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rebound pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h blood pressure profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MCLS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal and paternal stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Energy expenditure index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete target vessel occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Median embolization length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: PDAI score of 45 or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistent anti-DSG1 antibody values of 20 IU/mL or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: persistent anti-DSG3 antibody values of 130 IU/mL or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: subjective expectancy for a snake to bite
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: behavioral approach of snake images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variability in distress during exposure
Endpoint domain: Adverse events/effects
Primary endpoint: Vaccine efficacy against Covid-19
Endpoint domain: Mortality/survival
Primary endpoint: mean score of empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stigma prevalence and magnitude
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Optimal VC placement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of poor sleeping (PSQI > 5)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Choroid area change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choroid volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central venous pressure change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of clinical pericarditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of gastrointestinal discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Amyloid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F-FDG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TGA post-stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sinus rhythm on 7-day Holter after 1-year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sleep maintenance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: improvement in communication confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: accuracy of selection of empathic responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of IPT and CT compared to waitlist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BMD values at the knee regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Malnutrition Inflammation Score (MIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: spelling improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRS score of 0-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of weight bearing (WB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence for TDWB
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing